药物对比
Disopyramide vs Mavacamten
比较 Disopyramide 与 Mavacamten 在肥厚型心肌病（HCM）治疗中的选择。阐述其机制、疗效、安全性以及黑框警告的差异。
此页面暂无可用的对比维度。
临床背景
This comparison arises when considering medical therapies for patients with obstructive hypertrophic cardiomyopathy after first-line agents.
结论
Mavacamten offers targeted myosin inhibition for oHCM with a boxed warning, while Disopyramide is an older antiarrhythmic used off-label; neither is universally superior.
全部药物对比